Poolbeg Pharma (POLB) Insider Trading & Ownership GBX 7.18 -0.17 (-2.31%) (As of 11:53 AM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsHeadlinesInsider Trades Poolbeg Pharma (LON:POLB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.71%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)£116,624.04Number OfInsiders Selling(Last 12 Months)0 Get POLB Insider Trade Alerts Want to know when executives and insiders are buying or selling Poolbeg Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address POLB Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Poolbeg Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/21/2024Jeremy SkillingtonInsiderBuy154,764GBX 11£17,024.042/19/2024Cathal FrielInsiderBuy830,000GBX 12£99,600 (Data available from 1/1/2013 forward) POLB Insider Trading Activity - Frequently Asked Questions Who is on Poolbeg Pharma's Insider Roster? The list of insiders at Poolbeg Pharma includes Cathal Friel, and Jeremy Skillington. Learn more on insiders at POLB. What percentage of Poolbeg Pharma stock is owned by insiders? 24.71% of Poolbeg Pharma stock is owned by insiders. Learn more on POLB's insider holdings. Which Poolbeg Pharma insiders have been buying company stock? The following insiders have purchased POLB shares in the last 24 months: Cathal Friel (£99,600), and Jeremy Skillington (£17,024.04). How much insider buying is happening at Poolbeg Pharma? Insiders have purchased a total of 984,764 POLB shares in the last 24 months for a total of £116,624.04 bought. Poolbeg Pharma Key ExecutivesMr. Cathal Martin Friel (Age 60)Executive Chairman of The Board Compensation: $138kDr. Jeremy Skillington Ph.D. (Age 53)CEO & Director Compensation: $310kMr. Ian O'Connell (Age 37)CFO & Director Compensation: $220kCarol DaltonVice President of Investor Relations & Public RelationsMr. John McEvoySenior Vice President & Chief Legal OfficerMr. David James Allmond (Age 54)Chief Business Officer Mr. Salim Gulamabbas Hamir F.C.A.Company SecretaryMr. Ross CrockettGroup Financial Controller More Insider Trading Tools from MarketBeat Related Companies e-therapeutics Insider Ownership Tissue Regenix Group Insider Ownership Sareum Insider Ownership Oncimmune Insider Ownership BiVictriX Therapeutics Insider Ownership Fusion Antibodies Insider Ownership IXICO Insider Ownership Roquefort Therapeutics Insider Ownership Oxford BioDynamics Insider Ownership Destiny Pharma Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (LON:POLB) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poolbeg Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Poolbeg Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
